Basilea Pharmaceutica (XSWX:BSLN) Change In Receivables : CHF3.5 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Change In Receivables?

Basilea Pharmaceutica's change in receivables for the quarter that ended in Dec. 2023 was CHF6.2 Mil. It means Basilea Pharmaceutica's Accounts Receivable declined by CHF6.2 Mil from Jun. 2023 to Dec. 2023 .

Basilea Pharmaceutica's change in receivables for the fiscal year that ended in Dec. 2023 was CHF3.5 Mil. It means Basilea Pharmaceutica's Accounts Receivable declined by CHF3.5 Mil from Dec. 2022 to Dec. 2023 .

Basilea Pharmaceutica's Accounts Receivable for the quarter that ended in Dec. 2023 was CHF27.9 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Basilea Pharmaceutica's Days Sales Outstanding for the six months ended in Dec. 2023 was 69.99.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Basilea Pharmaceutica's liquidation value for the six months ended in Dec. 2023 was CHF-89.3 Mil.

Basilea Pharmaceutica Change In Receivables Historical Data

The historical data trend for Basilea Pharmaceutica's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Change In Receivables Chart

Basilea Pharmaceutica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

6.45

-4.12

-32.06

2.59

3.45

Basilea Pharmaceutica Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-36.27	25.76	-23.17	-2.75	6.20

Basilea Pharmaceutica Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF3.5 Mil.

Basilea Pharmaceutica (XSWX:BSLN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Basilea Pharmaceutica's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	27.891	/	72.729	*	91
=	69.99

2. In Ben Graham's calculation of liquidation value, Basilea Pharmaceutica's accounts receivable are only considered to be worth 75% of book value:

Basilea Pharmaceutica's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	59.9	-	183.291	+	0.75 * 27.891	+	0.5 * 26.41
=	-89.3

Basilea Pharmaceutica Change In Receivables Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Basilea Pharmaceutica (XSWX:BSLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (XSWX:BSLN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

BSLNz:UK

Address

Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058

Website

https://www.basilea.com

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (XSWX:BSLN) Headlines

No Headlines